InsiderClue
← All stocks

Equillium, Inc.

EQ Net selling
CIK 0001746466 #4146 in the set updated 21 Sep 2026
Bought (120 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$5.57M
$150.04K on a plan · $2.09M straight out of an exercise
Sold at will
$3.33M
17 of 50 sales
Net
−$5.57M
−$3.33M against sales at will

By person

8 insiders · 50 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Connelly Stephen
President and CSO
—
$3.40M (12)
−$3.40M
762,025
1.20%
$2.24M
−41.1%
Zedelmayer Christine
Sr. Vice President and COO
—
$1.59M (17) scheduled
−$1.59M
62,586
0.0987%
$184.01K
−27.1%
Keyes Jason A
Chief Financial Officer
—
$351.56K (16)
−$351.56K
237,353
0.3743%
$697.84K
−16.3%
Tom Penny
Principal Accounting Officer
—
$237.56K (5) scheduled
−$237.56K
0
0.0000%
$0.00
−100.0%
BRADBURY DANIEL
CHAIRMAN
—
—
—
3,711,995
5.85%
$10.91M
+1.3%
Steel Bruce D.
Chief Executive Officer
—
—
—
3,711,995
5.85%
$10.91M
+1.3%
Biocon SA
10% owner
—
—
—
2,316,134
3.65%
$6.81M
+10.9%
Rothman Joel
Chief Development Officer
—
—
—
58,150
0.0917%
$170.97K
+281.3%

Individual transactions

20
Insider
Date
Role
Action
Shares
Price
Amount
Zedelmayer Christine
5 Jun 2026
Sr. Vice President and COO
Sold after exercise
14,584
$2.93
$42.74K
Zedelmayer Christine
28 May 2026
Sr. Vice President and COO
Sold after exercise
30,208
$2.98
$90.02K
Zedelmayer Christine
28 May 2026
Sr. Vice President and COO
Sold after exercise
200
$2.71
$542.00
Zedelmayer Christine
28 May 2026
Sr. Vice President and COO
Sold after exercise
55,604
$2.70
$150.13K
Tom Penny
28 May 2026
Principal Accounting Officer
Sold after exercise
65,000
$2.95
$191.75K
Zedelmayer Christine
27 May 2026
Sr. Vice President and COO
Sold after exercise
9,821
$2.70
$26.52K
Zedelmayer Christine
13 Mar 2026
Sr. Vice President and COO
Sold after exercise
120,312
$2.50
$300.82K
Zedelmayer Christine
9 Mar 2026
Sr. Vice President and COO
Sold after exercise
181,219
$2.00
$362.44K
Zedelmayer Christine
19 Feb 2026
Sr. Vice President and COO
Sold after exercise
76,562
$1.74
$133.26K
Zedelmayer Christine
19 Feb 2026
Sr. Vice President and COO
Sold after exercise
109,375
$1.78
$194.84K
Zedelmayer Christine
23 Dec 2025
Sr. Vice President and COO
Sold after exercise
100,000
$1.50
$150.00K
Zedelmayer Christine
16 Nov 2021
Sr. Vice President and COO
Sold after exercise
7,350
$5.49
$40.31K
Zedelmayer Christine
16 Nov 2021
Sr. Vice President and COO
Sold after exercise
4,084
$5.49
$22.40K
Connelly Stephen
6 Oct 2021
Chief Scientific Officer
Sold after exercise
2,467
$7.01
$17.29K
Connelly Stephen
6 Oct 2021
Chief Scientific Officer
Sold after exercise
5,625
$7.01
$39.42K
Connelly Stephen
8 Jun 2021
Chief Scientific Officer
Sold after exercise
10,495
$7.18
$75.32K
Connelly Stephen
7 Jun 2021
Chief Scientific Officer
Sold after exercise
13,900
$7.14
$99.26K
Connelly Stephen
7 Jun 2021
Chief Scientific Officer
Sold after exercise
8,490
$7.08
$60.14K
Connelly Stephen
4 Jun 2021
Chief Scientific Officer
Sold after exercise
7,030
$7.01
$49.25K
Connelly Stephen
4 Jun 2021
Chief Scientific Officer
Sold after exercise
6,509
$7.01
$45.60K
Show all 50 transactions →

What was left out

Form 4 filings counted 157
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 13
Sales straight out of an exercise 20
Sales at will 17
Transactions with no price 0
Shares from compensation/vesting 1,297,109
Sales filed before the plan box existed 15
History held since 16 Oct 2018